Floatz logo

Elcubragistat

Diabetic Neuropathy

Abide TherapeuticsSmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

25 Active assets in the Diabetic Neuropathy cohort.

Asset / SponsorPhaseRating
Duloxetine
Aga Khan University
Phase 4A
Mirogabalin
Bangladesh Medical University
Phase 4BBB
Gabapentin
Aziende Chimiche Riunite Angelini Francesco S.p.A
Phase 4BBB
Capsaicin
Corporacion Parc Tauli
Phase 4BBB
Pregabalin
Shandong Suncadia Medicine Co., Ltd.
Phase 4BBB

View all 50 →

Same molecule, other indications

Elcubragistat is also rated in:

transverse myelitisDormant
CC
Indicative · Phase 1
47 / 100
View asset →
postherpetic neuralgiaDormant
CC
Indicative · Phase 1
47 / 100
View asset →
neuromyelitis opticaDormant
CC
Indicative · Phase 1
46 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →